IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
100 hedge funds and large institutions have $431M invested in IVERIC bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 47 increasing their positions, 24 reducing their positions, and 29 closing their positions.
147% more call options, than puts
Call options by funds: $5.44M | Put options by funds: $2.2M
96% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 24
10% more capital invested
Capital invested by funds: $391M → $431M (+$40M)
16% less funds holding
Funds holding: 119 → 100 (-19)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
62% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$9.88M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.92M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$5.47M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.02M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
-$8.8M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.59M |
| 3 |
Renaissance Technologies
New York
|
-$4.26M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$3.84M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.11M |
ISEE Hedge Fund Activity: Q3 2020 in Review
100 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2020, worth a combined $431M — up 10% from $391M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ISEE and 11 opened new positions — a net loss of 18 holders — while 24 trimmed existing stakes and 47 added.
The largest buyer was BlackRock, adding an estimated $9.88M. The largest seller was Versant Venture Management, exiting entirely with an estimated $8.8M sold.
- 100 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2020, down from 119 in Q2 2020.
- Funds reported $431M of IVERIC bio, Inc. Common Stock stock for Q3 2020, up 10% quarter-over-quarter.
- 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2020 and 29 closed out, a net change of -18 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $9.88M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q3 2020 was Versant Venture Management, an estimated $8.8M sold.
Based on aggregated 13F filings for Q3 2020.